首页> 美国卫生研究院文献>Experimental Diabetes Research >Simple Cystatin C Formula for Estimation of Glomerular Filtration Rate in Overweight Patients with Diabetes Mellitus Type 2 and Chronic Kidney Disease
【2h】

Simple Cystatin C Formula for Estimation of Glomerular Filtration Rate in Overweight Patients with Diabetes Mellitus Type 2 and Chronic Kidney Disease

机译:简单的胱抑素C公式估算超重2型糖尿病和慢性肾脏病患者的肾小球滤过率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In clinical practice the glomerular filtration rate (GFR) is estimated from serum creatinine-based equations like the Cockcroft-Gault formula (C&G) and Modification of Diet in Renal Disease formula (MDRD). Recently, serum cystatin C-based equations, the newer creatinine formula (The Chronic Kidney Disease Epidemiology Collaboration formula (CKD-EPI)), and equation that use both serum creatinine and cystatin C (CKD-EPI creatinine & cystatin formula) were proposed as new GFR markers. Present study compares serum creatinine-based equations, combined (including both serum creatinine and cystatin C) equation, and serum simple cystatin C formula (100/serum cystatin C) against 51CrEDTA clearance in 113 adult overweight Caucasians with diabetes mellitus type 2 (DM2) and chronic kidney disease (CKD). The results of present study demonstrated that the simple cystatin C formula could be a useful tool for the evaluation of renal function in overweight patients with DM2 and impaired kidney function in daily clinical practice in hospital and especially in outpatients. Despite the advantages of the simple cystatin C formula, cystatin C-based equations cannot completely replace the “gold standard” for estimation of the GFR in a population of DM2 patients with CKD, but may contribute to a more accurate selection of patients requiring such invasive and costly procedures.
机译:在临床实践中,肾小球滤过率(GFR)是根据基于血清肌酐的方程式估算的,例如Cockcroft-Gault公式(C&G)和“饮食中肾脏疾病的改善”公式(MDRD)。最近,有人提出了基于血清胱抑素C的方程式,较新的肌酐公式(慢性肾脏病流行病学协作公式(CKD-EPI))以及同时使用血清肌酐和胱抑素C的方程式(CKD-EPI肌酐和胱抑素配方)作为新的GFR标记。本研究比较了113例2型糖尿病超重高加索白种人的51CrEDTA清除率,比较了基于血清肌酐的方程式,组合(包括血清肌酐和半胱氨酸蛋白酶抑制剂C方程)和血清简单半胱氨酸蛋白酶抑制剂C公式(100 /血清半胱氨酸蛋白酶抑制剂C)对51CrEDTA清除率。和慢性肾脏病(CKD)。目前的研究结果表明,简单的半胱氨酸蛋白酶抑制剂C配方可以作为评估超重DM2和肾脏功能受损患者超重肾功能的有用工具,在医院,尤其是门诊的日常临床实践中。尽管简单的胱抑素C公式具有优势,但基于胱抑素C的方程无法完全替代“金标准”来估计DM2 CKD患者群体中的GFR,但可能有助于更准确地选择需要这种侵入性治疗的患者和昂贵的程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号